ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Oklahoma Medicaid Tests New Tactic to Curb U.S. Drug Costs

Deena Beasley  |  August 23, 2018

LOS ANGELES (Reuters)—A new front in the battle over the cost of expensive medicines in the United States is opening up in Oklahoma, the first state where the government’s Medicaid program is negotiating contracts for prescription drugs based on how well they work. In June, Oklahoma received approval from the U.S. Centers for Medicare and…

Filed under:Drug UpdatesPractice Support Tagged with:Alkermes PlcAristada (aripiprazole lauroxil)drug costsnegotiating contractsOklahoma Medicaid programPrescription drugsU.S. Centers for Medicare and Medicaid Services (CMS)

Studies Find More Evidence the Microbiome Affects Autoimmune Disease

Kurt Ullman  |  August 17, 2018

Evidence is accumulating that the microbiome may be an important part of the pathogenesis of many autoimmune diseases. Two recently published articles report on how translocation of the gut bacterium Enterococcus gallinarum drives autoimmunity in mice and humans, and on the role of other commensal bacteria in triggering immune responses—specifically to the autoantigen Ro60, which…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:gut microbiomeMicrobiome

The State of the Science: Annual Research Meetings Foster Collaboration & Mentorship

David Daikh, MD, PhD, & Abby Abelson, MD, FACR  |  August 16, 2018

The 11th annual Investigators’ Meeting and the Rheumatology Research Workshop, held in June in San Francisco, were by all accounts great successes. California sunshine greeted more than 120 attendees as we came together to share the latest advances and updates in rheumatology research. These annual meetings have something for every research professional, whether you work…

Filed under:Career DevelopmentPresident's Perspective Tagged with:REF Investigators’ MeetingRheumatology Research Workshop

From Dog Clickers to Scripts—Thoughts on Learning to Teach

Philip Seo, MD, MHS  |  August 16, 2018

You can purchase a dog clicker for about $3 on Amazon. If you don’t own a dog, this is not a useful piece of information. I don’t own a dog, and the first time I heard the phrase dog clicker, I thought—I think understandably—that it was some sort of remote control. If you don’t own…

Filed under:Career DevelopmentEducation & TrainingOpinionRheuminationsSpeak Out Rheum Tagged with:Preceptorshipteaching physicians

EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray

Michele B. Kaufman, PharmD, BCGP  |  August 8, 2018

In late July, the European Commission granted marketing approval for Hyrimoz, which is biosimilar to adalimumab…

Filed under:AnalgesicsBiologics/DMARDsDrug Updates Tagged with:adalimumabBiologics & BiosimilarsBiosimilarsbuprenorphine sublingual sprayDrug SafetyEuropean UnionFDAHyrimozInternationalPainSafetyU.S. Food and Drug Administration (FDA)

Switch to Electronic Health Records Tied to Fewer Hospital Deaths

Lisa Rapaport  |  July 27, 2018

(Reuters Health)—Hospitals that switch from paper to electronic health records may eventually see lower death rates than they had before, but a U.S. study also suggests that fatalities may first increase as the transition gets underway. Researchers examined the degree of digitization and 30-day death rates for patients age 65 and older at 3,249 hospitals…

Filed under:EMRsPractice SupportTechnology Tagged with:Electronic health recordsJulia Adler-Milsteinlower death rates

COIN Launches Playbook to Reach Young Adult Audiences

From the College  |  July 19, 2018

The ACR’s Collaborative Initiatives (COIN) department develops and tests innovative solutions for complex rheumatology care problems. “All of the work COIN does—programs toward health equity, creating models to increase rheumatology-related capacity in places of need, building bridges with local and national patient organizations—is done on [behalf of its members],” says Dr. David Daikh. Each month…

Filed under:From the CollegeSystemic Lupus Erythematosus Tagged with:American College of Rheumatology (ACR)Collaboration InitiativesCollaborative Initiatives Special Committee (COIN)LupusSocial Media

Rheumatologists in U.S. on J-1 Visas Face Challenges After Fellowship

Shing Law, BM, BCh  |  July 19, 2018

I am an alien rheumatologist. Are you? One in five rheumatology fellows is considered an alien. Under the Code of Federal Regulations Title 22 Chapter I Subchapter G Part 62 Subpart B Section 62.27, an alien physician is a foreign national who is a graduate of a school of medicine who comes to the U.S….

Filed under:Professional Topics Tagged with:alien physiciansforeign nationals

Medical Tech-Tool Usage Is Surging

Susan Bernstein  |  July 19, 2018

Technology in medicine is no longer new or trendy. It’s pervasive. Rheumatologists may now assume a patient has searched online for information about his or her diagnosis or potential therapies. Both physicians and rheumatology health professionals should acknowledge their patients’ Internet surfing and find out what they’ve read, says Betsy Roth-Wojcicki, RN, MS, CPNP, an…

Filed under:AppsTechnology Tagged with:Social Media

Support Groups Can Help Rheumatic Disease Patients

The ARHP Practice Committee & Joan Westreich, LCSW-R  |  July 19, 2018

Fifteen women and men seated around a conference table in a New York City hospital listen intently to one of their peers. A 40-year-old elementary school teacher shares her challenges related to the intersection of rheumatoid arthritis (RA) and the responsibilities of a demanding job.* With the support and counsel of fellow group members, the…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)self-managementsupport group

  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences